Intervention in at-risk states for developing psychosis.

Saved in:
Bibliographic Details
Title: Intervention in at-risk states for developing psychosis.
Authors: Ruhrmann, Stephan, Schultze-Lutter, Frauke, Bechdolf, Andreas, Klosterkötter, Joachim
Source: European Archives of Psychiatry & Clinical Neuroscience. Oct2010, Vol. 260, p90-94. 5p.
Subjects: Schizophrenia, Psychoses, Omega-3 fatty acids, Psychotherapy, Pharmacology
Abstract: Indicated prevention is currently one of the most promising approaches to fight the individual and societal burden associated with psychosis and particularly schizophrenia. The number of studies is still limited, yet encouraging results have been reported from pharmacological and psychotherapeutic trials. Furthermore, it has become clear that persons characterized by the at-risk criteria are already ill and do not only need preventive intervention but also treatment. As is indicated by a recent study successfully using omega-3 fatty acids for both purposes, it may be promising to develop and investigate interventions especially for the at-risk state, independent of their effectiveness in manifest disease states. An overview on the current findings and ongoing research in this area is provided. [ABSTRACT FROM AUTHOR]
Copyright of European Archives of Psychiatry & Clinical Neuroscience is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 54632889
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Intervention in at-risk states for developing psychosis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Ruhrmann%2C+Stephan%22">Ruhrmann, Stephan</searchLink><br /><searchLink fieldCode="AR" term="%22Schultze-Lutter%2C+Frauke%22">Schultze-Lutter, Frauke</searchLink><br /><searchLink fieldCode="AR" term="%22Bechdolf%2C+Andreas%22">Bechdolf, Andreas</searchLink><br /><searchLink fieldCode="AR" term="%22Klosterkötter%2C+Joachim%22">Klosterkötter, Joachim</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22European+Archives+of+Psychiatry+%26+Clinical+Neuroscience%22">European Archives of Psychiatry & Clinical Neuroscience</searchLink>. Oct2010, Vol. 260, p90-94. 5p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Schizophrenia%22">Schizophrenia</searchLink><br /><searchLink fieldCode="DE" term="%22Psychoses%22">Psychoses</searchLink><br /><searchLink fieldCode="DE" term="%22Omega-3+fatty+acids%22">Omega-3 fatty acids</searchLink><br /><searchLink fieldCode="DE" term="%22Psychotherapy%22">Psychotherapy</searchLink><br /><searchLink fieldCode="DE" term="%22Pharmacology%22">Pharmacology</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Indicated prevention is currently one of the most promising approaches to fight the individual and societal burden associated with psychosis and particularly schizophrenia. The number of studies is still limited, yet encouraging results have been reported from pharmacological and psychotherapeutic trials. Furthermore, it has become clear that persons characterized by the at-risk criteria are already ill and do not only need preventive intervention but also treatment. As is indicated by a recent study successfully using omega-3 fatty acids for both purposes, it may be promising to develop and investigate interventions especially for the at-risk state, independent of their effectiveness in manifest disease states. An overview on the current findings and ongoing research in this area is provided. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of European Archives of Psychiatry & Clinical Neuroscience is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=54632889
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00406-010-0139-5
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 5
        StartPage: 90
    Subjects:
      – SubjectFull: Schizophrenia
        Type: general
      – SubjectFull: Psychoses
        Type: general
      – SubjectFull: Omega-3 fatty acids
        Type: general
      – SubjectFull: Psychotherapy
        Type: general
      – SubjectFull: Pharmacology
        Type: general
    Titles:
      – TitleFull: Intervention in at-risk states for developing psychosis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ruhrmann, Stephan
      – PersonEntity:
          Name:
            NameFull: Schultze-Lutter, Frauke
      – PersonEntity:
          Name:
            NameFull: Bechdolf, Andreas
      – PersonEntity:
          Name:
            NameFull: Klosterkötter, Joachim
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 10
              Text: Oct2010
              Type: published
              Y: 2010
          Identifiers:
            – Type: issn-print
              Value: 09401334
          Numbering:
            – Type: volume
              Value: 260
          Titles:
            – TitleFull: European Archives of Psychiatry & Clinical Neuroscience
              Type: main
ResultId 1